Machine Learning-Based Treatment Allocation for Recurrent Hepatocellular Carcinoma

JAMA Surg. 2023 Oct 1;158(10):1113-1114. doi: 10.1001/jamasurg.2023.1673.

Authors

Yasuyuki Shigematsu^{1

2}, Kentaro Inamura^{1

2}

Affiliations

¹ Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
² Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.

PMID: 37256581
DOI: 10.1001/jamasurg.2023.1673

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular* / pathology
Carcinoma, Hepatocellular* / surgery
Humans
Liver Neoplasms* / pathology
Liver Neoplasms* / surgery
Machine Learning